ArticleFrontiers in oncology2026
From AI-based image analysis to surgical decision support in prostate cancer: interdisciplinary application of the international radiomics platform.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Diagnosis and surgical therapy planning for prostate cancer patients are often hindered by fragmented workflows and a lack of integrated, data-driven analysis - barriers that specifically impede the effective deployment of machine learning (ML)-based risk stratification and clinical decision support. The aim of this exploratory study was to clinically implement and prospectively validate a platform-based multimodal data analysis pipeline within a radiological-urological collaboration. Materials and methods: In this single center analysis, a total of 249 patients (176 retrospectively, 73 prospectively) undergoing radical prostatectomy were included. Multimodal datasets, including preoperative multiparametric MRI, clinical, laboratory, and pathological data, were harmonized and imported into the International Radiomics Platform (IRP). Radiomics features were extracted and machine learning models were constructed to predict extracapsular extension (ECE), nerve-sparing approach decision, and positive surgical margin (PSM) risk. Results are reported as area under the curve (AUC) values including 95% confidence intervals. Results: A cloud-based software prototype was implemented based on the IRP, integrating prediction models for clinical decision support. Using a step-wise modeling approach, prediction of extracapsular extension (ECE) improved substantially when imaging-derived parameters (e.g. PI-RADS scores, tumor-capsule contact length) were added to conventional clinical parameters (AUC 0.90, 95% CI: 0.86-0.94 vs. 0.71, 95% CI: 0.63-0.77). In contrast, the addition of imaging-derived features provided no meaningful incremental value for predicting positive surgical margins (PSM; AUC 0.60, 95% CI: 0.52-0.68) or nerve-sparing approach decisions (AUC 0.79, 95% CI: 0.73-0.83), which were also unchanged by the further inclusion of quantitative radiomics features. Performance was consistent across internal cross-validation and prospective external validation. Conclusion: This exploratory study demonstrates the feasibility of a platform-based, multimodal data analysis workflow for prostate cancer surgical planning. Integration of imaging-derived parameters meaningfully enhanced ECE prediction, while radiomics offered no additional benefit beyond standard imaging. These findings highlight both the potential and current limitations of AI-driven workflow integration in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.